{"id":4429,"date":"2008-03-06T00:00:00","date_gmt":"2008-03-06T00:00:00","guid":{"rendered":"https:\/\/mci.pl\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics\/"},"modified":"2008-03-06T00:00:00","modified_gmt":"2008-03-06T00:00:00","slug":"mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics","status":"publish","type":"post","link":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics","title":{"rendered":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics ."},"content":{"rendered":"<p>In its first investment MCI.BioVentures fund acquired Ge<!--more-->nomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients.<\/p>\n<p>The discovery of sequence of bases in human DNA (human genome sequencing) has been one of the most significant achievements of science and technology in recent years. Apart from correct information DNA molecules also carry incorrect information (mutations or polymorphisms) which in some cases can cause serious genetic diseases or increase the probability of manifestations of such diseases. Early knowledge of susceptibility is in many cases critical for determining a correct therapy or changes in lifestyle which might alleviate or prevent the occurrence of pathological symptoms.<\/p>\n<p>\u00e2\u0080\u009cThe investment in Genomed fits well the profile of operations of MCI.BioVentures fund. It is being conducted at the early stage of growth of the company providing biotechnological services operating on the basis of knowledge and experience of a team of excellent specialists. We are planning to make in total 4-6 similar investments by the end of 2008. The investment in Genomed was possible due to unique competences of the MCI.BioVentures investment team in the area of risk assessment of this type of investments\u00e2\u0080\u009d &#8211; says Grzegorz Gromada, President of the Management Board of MCI.BioVentures.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In its first investment MCI.BioVentures fund acquired Ge<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"protect_children":false,"inline_featured_image":false,"footnotes":""},"categories":[56,57],"tags":[],"class_list":["post-4429","post","type-post","status-publish","format-standard","hentry","category-news","category-press-releases"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"k.karkoszka\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Grupa MCI - Wiod\u0105cy inwestor technologiczny na rynkach Wschodz\u0105cej Europy\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI\" \/>\n\t\t<meta property=\"og:description\" content=\"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2008-03-06T00:00:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2008-03-06T00:00:00+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI\" \/>\n\t\t<meta name=\"twitter:description\" content=\"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#blogposting\",\"name\":\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI\",\"headline\":\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .\",\"author\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/author\\\/k-karkoszka#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/#organization\"},\"datePublished\":\"2008-03-06T00:00:00+01:00\",\"dateModified\":\"2008-03-06T00:00:00+01:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#webpage\"},\"articleSection\":\"News, Press Releases\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mci.pl\\\/en\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/kategoria\\\/news#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/kategoria\\\/news#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/mci.pl\\\/kategoria\\\/news\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#listItem\",\"name\":\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#listItem\",\"position\":3,\"name\":\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/mci.pl\\\/kategoria\\\/news#listItem\",\"name\":\"News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/#organization\",\"name\":\"Grupa MCI Capital S.A.\",\"description\":\"Wiod\\u0105cy inwestor technologiczny na rynkach Wschodz\\u0105cej Europy\",\"url\":\"https:\\\/\\\/mci.pl\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/author\\\/k-karkoszka#author\",\"url\":\"https:\\\/\\\/mci.pl\\\/en\\\/author\\\/k-karkoszka\",\"name\":\"k.karkoszka\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/431f3f10126e2c9d5362b29445b7f41031d128fff924dea17851efeab3ebfe86?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"k.karkoszka\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#webpage\",\"url\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics\",\"name\":\"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI\",\"description\":\"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/author\\\/k-karkoszka#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/author\\\/k-karkoszka#author\"},\"datePublished\":\"2008-03-06T00:00:00+01:00\",\"dateModified\":\"2008-03-06T00:00:00+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/mci.pl\\\/en\\\/\",\"name\":\"Grupa MCI\",\"description\":\"Wiod\\u0105cy inwestor technologiczny na rynkach Wschodz\\u0105cej Europy\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/mci.pl\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI","description":"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery","canonical_url":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#blogposting","name":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI","headline":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .","author":{"@id":"https:\/\/mci.pl\/en\/author\/k-karkoszka#author"},"publisher":{"@id":"https:\/\/mci.pl\/en\/#organization"},"datePublished":"2008-03-06T00:00:00+01:00","dateModified":"2008-03-06T00:00:00+01:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#webpage"},"isPartOf":{"@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#webpage"},"articleSection":"News, Press Releases"},{"@type":"BreadcrumbList","@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/mci.pl\/en#listItem","position":1,"name":"Home","item":"https:\/\/mci.pl\/en","nextItem":{"@type":"ListItem","@id":"https:\/\/mci.pl\/kategoria\/news#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/mci.pl\/kategoria\/news#listItem","position":2,"name":"News","item":"https:\/\/mci.pl\/kategoria\/news","nextItem":{"@type":"ListItem","@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#listItem","name":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics ."},"previousItem":{"@type":"ListItem","@id":"https:\/\/mci.pl\/en#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#listItem","position":3,"name":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .","previousItem":{"@type":"ListItem","@id":"https:\/\/mci.pl\/kategoria\/news#listItem","name":"News"}}]},{"@type":"Organization","@id":"https:\/\/mci.pl\/en\/#organization","name":"Grupa MCI Capital S.A.","description":"Wiod\u0105cy inwestor technologiczny na rynkach Wschodz\u0105cej Europy","url":"https:\/\/mci.pl\/en\/"},{"@type":"Person","@id":"https:\/\/mci.pl\/en\/author\/k-karkoszka#author","url":"https:\/\/mci.pl\/en\/author\/k-karkoszka","name":"k.karkoszka","image":{"@type":"ImageObject","@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/431f3f10126e2c9d5362b29445b7f41031d128fff924dea17851efeab3ebfe86?s=96&d=mm&r=g","width":96,"height":96,"caption":"k.karkoszka"}},{"@type":"WebPage","@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#webpage","url":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics","name":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI","description":"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/mci.pl\/en\/#website"},"breadcrumb":{"@id":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics#breadcrumblist"},"author":{"@id":"https:\/\/mci.pl\/en\/author\/k-karkoszka#author"},"creator":{"@id":"https:\/\/mci.pl\/en\/author\/k-karkoszka#author"},"datePublished":"2008-03-06T00:00:00+01:00","dateModified":"2008-03-06T00:00:00+01:00"},{"@type":"WebSite","@id":"https:\/\/mci.pl\/en\/#website","url":"https:\/\/mci.pl\/en\/","name":"Grupa MCI","description":"Wiod\u0105cy inwestor technologiczny na rynkach Wschodz\u0105cej Europy","inLanguage":"en-US","publisher":{"@id":"https:\/\/mci.pl\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Grupa MCI - Wiod\u0105cy inwestor technologiczny na rynkach Wschodz\u0105cej Europy","og:type":"article","og:title":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI","og:description":"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery","og:url":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics","article:published_time":"2008-03-06T00:00:00+00:00","article:modified_time":"2008-03-06T00:00:00+00:00","twitter:card":"summary_large_image","twitter:title":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics . - Grupa MCI","twitter:description":"In its first investment MCI.BioVentures fund acquired Genomed Sp. z o.o. based in Warsaw. The company operates in the new fast-growing market for provision of services in the scope of medical molecular diagnostics, consanguinity tests as well as DNA sequencing and synthesis DNA for pharmaceutical and biotechnological companies, research institutions and individual clients. The discovery"},"aioseo_meta_data":{"post_id":"4429","title":null,"description":null,"keywords":null,"keyphrases":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"created":"2022-08-04 16:36:16","updated":"2026-09-10 05:34:18","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/mci.pl\/en\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/mci.pl\/kategoria\/news\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tMCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/mci.pl\/en"},{"label":"News","link":"https:\/\/mci.pl\/kategoria\/news"},{"label":"MCI.BioVentures, the first biotechnology fund in Poland, invests in modern molecular diagnostics .","link":"https:\/\/mci.pl\/en\/mci-bioventures-the-first-biotechnology-fund-in-poland-invests-in-modern-molecular-diagnostics"}],"_links":{"self":[{"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/posts\/4429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/comments?post=4429"}],"version-history":[{"count":0,"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/posts\/4429\/revisions"}],"wp:attachment":[{"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/media?parent=4429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/categories?post=4429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mci.pl\/en\/wp-json\/wp\/v2\/tags?post=4429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}